National Methadone Conference 2001 Sponsored by American Methadone Treatment Association

Attention: This
presentation contains pictures and takes time to download. 

Please be patient!

Opioid Treatment in the 21st Century: Implementing the Vision

St. Louis

October 7-10, 2001

St. Louis Arch

Five YEAR PLAN AVAILABLE IN POLICY MAKERS LUNCHEON SECTION

 

Advocacy Events and Patient Participation

NAMA at AMTA Conference 2001

Sunday, October 7th

Pre-conference Meeting 9 A.M. to 5 P.M.
Unifying the Treatment Community
Moderator Todd Rosendale, Center for Substance Abuse Treatment
Speakers

  • Fred Christie, AFFIRM (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

(Sponsored by the Center for Substance Abuse Treatment)

The First Patients Advocates Illumination Award 4 P.M.
Chair Todd Rosendale, Center for Substance Abuse Treatment
Presented by Joycelyn Woods, NAMA

The Advocacy Coalition will present the first patient’s Advocates Illumination Award to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment.

Presented to Dr. Marc Shinderman and the Center for Addiction Problems

(Sponsored by the Center for Substance Abuse Treatment)

Welcome Reception 6 P.M.

Monday, October 8th

Opening Address 8 A.M.

Policy Makers Luncheon 11 A.M. to 1 P.M.

Chair Mark Parrino, American Methadone Treatment Association

The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and
organizational representatives (i.e. ASAM, NAMA). The luncheon was initiated as a way to get the regulatory bodies together for discussions prior to changes in the federal regulation.

(Sponsored by the American Methadone Treatment Association)

Poster Session 2 P.M. 

The
Hepatitis C POSTER SESSION IS AVAILABLE AS POWERPOINT PRESENTATION ONLY! 

DOWNLOAD HCV PowerPoint Presentation

Hepatitis C and the Methadone Patient              
Authors

  • Tony Scro, NAMA Board of Directors (Grievance Coordinator) and ABATE (President)
  • Rokki Baker, NAMA Board of Directors (Chapter Coordinator), NAMA Nor-Cal (President) and Santa Cruz Hepatitis C Task Force
  • John Finger, NAMA (Regional Director), TexNAMA (President)
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist),TexNAMA (Vice President)

NAMA Organizational Meeting 7 P.M.
Chairs
Jo Sotheran, NAMA Board of Directors (Treasurer)
Joycelyn Woods, NAMA Board of Directors (President)

Many organizations use the conference as an opportunity to meet and NAMA is no different. Twenty-six NAMA representatives from around the country met to discuss patient advocacy issues.

Tuesday, October 9th

Hot Topic Round Table 2 P.M.
Administrative Detox: Necessary Use or Abuse
Authors

  • Joe Neuberger, Delaware NAMA (President)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee

Award Banquet 8 P.M.

The first conference of the new millennium heralds the recognition and acceptance of patient advocacy. For the first time no less than three awards were presented to patient advocates recognizing their work.

Wednesday, October 10th

Workshop 8 A.M.
Past, Present and Future: A Selection of Unfinished Business in Methadone Treatment
Authors

  • Moderator, Howard Lotsof, NAMA Acting Membership Director
  • Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President)
  • Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

Press Conference 12 P.M.
Director Jeanne Henry, Office of Public Affairs, Sate of Missouri, Department of Mental Health

Patient Advocacy Interviews Organized by Norma Alexander, NAMA Media Director
Interviews

  • Joycelyn Woods, NAMA Board of Directors (President)
  • Howard Lotsof, NAMA Acting Membership Director
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist) and TexNAMA (Vice President)

Sponsored by State of Missouri, Department of Mental Health

Closing Address 12 P.M.

Smoozing Around The Conference

A quick photo album of the conference.

 

NAMA HOME PAGE

Similar Posts

  • Internet Resources

    Admin 05/29/2021

    Treatment Facility Locator Buprenorphine Physician Locator Maintenance Assistance Point (Europe) Indro’s Coordinating and Information Resource Center for International Travel Traveler’s Health Kit Office of National Drug Control Policy Center For Substance Abuse Treatment CSAT Patient Support & Community Education Project Program Version (PDF Format) National Clearinghouse Opioid Drugs in Maintenance and Detoxification Treatment of Opiate…

  • At ATTOD

    Admin 02/19/2022

    Methadone Advocate Training   Want to know what a Methadone Conference is like? Check out our report on the NAMA website methadone.org                         FIRST EVER METHADONE (MAT) ADVOCATE TRAINING AND CERTIFICATION AT THE 2003 AATOD CONFERENCE IN Washington, DC SATURDAY APRIL 12, 2003 Information about the first ever CMA Training at AATOD on April 12,…

  • Diluting Methadone To Liquid Form – Practice, Negative Impact, Diversion

    Admin 12/28/2021

    The dilution of methadone with water was initiated as a result of the first federal methadone regulations because it was believed that this policy would reduce the diversion of methadone. While initially this policy may have had an impact within a short time most prospective buyers learning that methadone was now diluted with water and…

  • Report

    Admin 08/04/2022

    Exciting Developments in the UK Alan Joyce Methadone Alliance November 21, 2003 There are exciting things happening in the UK that the Methadone Alliance has been involved with. In the UK there is a type of General Practitioner (Doctor, in what you call ‘office based practice’, what we call ‘General practice’), who gain additional qualifications…

  • Federal Regulations

    Admin 10/06/2022

    Education Series Number 10 June 2004 The New Federal Regulations What Do They Mean for Patients? Methadone treatment in the U.S. is changing before our eyes. Some of this change has been rapid; some of it will take years or decades. Some patients have heard about new federal regulations, including an end to automatic dose…

  • Sample Letter

    Admin 04/08/2021

    ________________________________ Your Name ________________________________ Address ________________________________ City, State, Zip Date____________________________         Honorable Senator  ________________ United States Senate Washington, DC  20515 Dear Senator _____________________: On February 11, 1999 Senator McCain introduced S423 the Addiction Free Treatment Act. This legislation was intended as a political assault on the Office of National Drug Control Policy…